Allakos Inc.
METHODS AND COMPOSITIONS FOR TREATING ALLERGIC OCULAR DISEASES

Last updated:

Abstract:

The present disclosure provides methods for the treatment of an allergic ocular disease (e.g., allergic conjunctivitis, keratoconjunctivitis, or giant papillary conjunctivitis). In particular, the present disclosure provides methods for the treatment of an allergic ocular disease through administration of antibodies that bind to human Siglec-8 or compositions comprising said antibodies. The present disclosure also provides articles of manufacture or kits comprising antibodies that bind to human Siglec-8 for the treatment of an allergic ocular disease.

Status:
Application
Type:

Utility

Filling date:

5 Nov 2021

Issue date:

26 May 2022